Article

Pharmacy School HQ

Alex Barker, PharmD, founder of Pharmacy School HQ, is a self-proclaimed "neopharmaphobic" clinical pharmacist in Michigan.

Alex Barker, PharmD, founder of Pharmacy School HQ, is a self-proclaimed "neopharmaphobic" clinical pharmacist in Michigan.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit: kitsawet | stock.adobe.com
Related Content
Ivermectin tablets
July 11th 2025

Four States Pass Laws Allowing OTC Ivermectin, More States Pending Legislation

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models
July 10th 2025

Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models

Aislinn Antrim, Managing Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Abstract representation of cholesterol levels with colorful particles floating. This illustrates complexity of blood components and cholesterol
July 10th 2025

With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided

Luke Halpern, Assistant Editor
Woman getting covid-19 vaccination at home
Published: July 10th 2025 | Updated: July 10th 2025

FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk

Luke Halpern, Assistant Editor